VST vs. CPH.TO

Last updated Jun 9, 2026

VST (Vistra Corp.) and CPH.TO (Cipher Pharmaceuticals Inc.) are both stocks. VST operates in Utilities - Independent Power Producers (Utilities), while CPH.TO operates in Drug Manufacturers - Specialty & Generic (Healthcare). Over the past 5 years, VST returned 54.75%/yr vs 56.53%/yr for CPH.TO. At a 0.11 correlation, their price movements are largely independent.

Performance

VST vs. CPH.TO - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Vistra Corp. (VST) and Cipher Pharmaceuticals Inc. (CPH.TO). The values are adjusted to include any dividend payments, if applicable.

Different Trading Currencies

VST is traded in USD, while CPH.TO is traded in CAD. To make them comparable, the CPH.TO values have been converted to USD using the latest available exchange rates.

Returns By Period

In the year-to-date period, VST achieves a -8.82% return, which is significantly lower than CPH.TO's 10.08% return.

VST

• 1D: -1.25%
• 1M: -0.56%
• YTD: -8.82%
• 6M: -11.33%
• 1Y: -14.96%
• 3Y*: 83.12%
• 5Y*: 54.75%
• 10Y*: —

CPH.TO

• 1D: -0.04%
• 1M: -16.23%
• YTD: 10.08%
• 6M: 14.24%
• 1Y: 24.86%
• 3Y*: 62.35%
• 5Y*: 56.53%
• 10Y*: 7.91%

*Multi-year figures are annualized to reflect compound growth (CAGR)

VST vs. CPH.TO - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
VST Vistra Corp.	-8.82%	17.66%	261.52%	70.73%	5.08%	19.57%	-11.87%	2.46%	24.95%	18.19%
CPH.TO Cipher Pharmaceuticals Inc.	10.08%	10.20%	138.31%	47.79%	104.02%	90.42%	-36.49%	-8.51%	-67.81%	7.26%

Correlation

The correlation between VST and CPH.TO is 0.03, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.03
Correlation (3Y) Calculated over the trailing 3-year period	0.11
Correlation (5Y) Calculated over the trailing 5-year period	0.09
Correlation (All Time) Calculated using the full available price history since Oct 4, 2016	0.11

Fundamentals

EPS VST : $8.60 CPH.TO : CA$1.19
PE Ratio VST : 17.07 CPH.TO : 14.22
PEG Ratio VST : 0.39 CPH.TO : 0.17
PS Ratio VST : 2.18 CPH.TO : 8.65
Total Revenue (TTM) VST : $17.20B CPH.TO : CA$50.92M
Gross Profit (TTM) VST : $1.12B CPH.TO : CA$37.95M
EBITDA (TTM) VST : $4.34B CPH.TO : CA$25.12M

Return for Risk

VST vs. CPH.TO — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

VST

VST Risk / Return Rank: 29
VST Sharpe Ratio Rank: 29
VST Sortino Ratio Rank: 28
VST Omega Ratio Rank: 28
VST Calmar Ratio Rank: 29
VST Martin Ratio Rank: 28

CPH.TO

CPH.TO Risk / Return Rank: 64
CPH.TO Sharpe Ratio Rank: 64
CPH.TO Sortino Ratio Rank: 65
CPH.TO Omega Ratio Rank: 61
CPH.TO Calmar Ratio Rank: 66
CPH.TO Martin Ratio Rank: 65

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

VST vs. CPH.TO - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Vistra Corp. (VST) and Cipher Pharmaceuticals Inc. (CPH.TO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	VST	CPH.TO	Difference
Sharpe ratio: Return per unit of total volatility	-0.31	0.59	-0.90
Sortino ratio: Return per unit of downside risk	-0.13	1.31	-1.44
Omega ratio: Gain probability vs. loss probability	0.98	1.15	-0.16
Calmar ratio: Return relative to maximum drawdown	-0.39	1.03	-1.43
Martin ratio: Return relative to average drawdown	-0.74	2.22	-2.96
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

VST vs. CPH.TO - Sharpe Ratio Comparison

The current VST Sharpe Ratio is -0.31, which is lower than the CPH.TO Sharpe Ratio of 0.59. The chart below compares the historical Sharpe Ratios of VST and CPH.TO, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	VST	CPH.TO	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	-0.31	0.59	-0.90
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	1.15	1.14	+0.01
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	—	0.13	—
Sharpe Ratio (All Time) Calculated using the full available price history	0.71	0.07	+0.64

Drawdowns

VST vs. CPH.TO - Drawdown Comparison

The maximum VST drawdown since its inception was -53.32%, smaller than the maximum CPH.TO drawdown of -98.29%. Use the drawdown chart below to compare losses from any high point for VST and CPH.TO.

Drawdown Indicators

	VST	CPH.TO	Difference
Max Drawdown Largest peak-to-trough decline	-53.32%	-98.29%	+44.97%
Max Drawdown (1Y) Largest decline over 1 year	-38.01%	-24.22%	-13.79%
Max Drawdown (3Y) Largest decline over 3 years	-48.80%	-46.02%	-2.78%
Max Drawdown (5Y) Largest decline over 5 years	-48.80%	-46.02%	-2.78%
Max Drawdown (10Y) Largest decline over 10 years	—	-95.16%	—
Current Drawdown Current decline from peak	-32.40%	-24.23%	-8.17%
Average Drawdown Average peak-to-trough decline	-13.69%	-65.74%	+52.05%
Ulcer Index Depth and duration of drawdowns from previous peaks	20.31%	11.22%	+9.09%

Volatility

VST vs. CPH.TO - Volatility Comparison

Vistra Corp. (VST) and Cipher Pharmaceuticals Inc. (CPH.TO) have volatilities of 14.60% and 13.93%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	VST	CPH.TO	Difference
Volatility (1M) Calculated over the trailing 1-month period	14.60%	13.93%	+0.67%
Volatility (6M) Calculated over the trailing 6-month period	37.50%	28.17%	+9.33%
Volatility (1Y) Calculated over the trailing 1-year period	48.38%	42.14%	+6.24%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	47.87%	49.98%	-2.11%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	42.18%	61.43%	-19.25%

Dividends

VST vs. CPH.TO - Dividend Comparison

VST's dividend yield for the trailing twelve months is around 0.62%, while CPH.TO has not paid dividends to shareholders.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016
CPH.TO Cipher Pharmaceuticals Inc.	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
VST Vistra Corp.	0.62%	0.56%	0.63%	2.13%	3.12%	2.64%	2.75%	2.17%	0.00%	0.00%	14.97%

Financials

VST vs. CPH.TO - Profitability Comparison

The chart below illustrates the profitability comparison between Vistra Corp. and Cipher Pharmaceuticals Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

VST - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Vistra Corp. reported a gross profit of 0.00 and revenue of 5.64B. Therefore, the gross margin over that period was 0.0%.

CPH.TO - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Cipher Pharmaceuticals Inc. reported a gross profit of 8.35M and revenue of 12.30M. Therefore, the gross margin over that period was 67.9%.

VST - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Vistra Corp. reported an operating income of 1.50B and revenue of 5.64B, resulting in an operating margin of 26.6%.

CPH.TO - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Cipher Pharmaceuticals Inc. reported an operating income of 5.50M and revenue of 12.30M, resulting in an operating margin of 44.7%.

VST - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Vistra Corp. reported a net income of 980.00M and revenue of 5.64B, resulting in a net margin of 17.4%.

CPH.TO - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Cipher Pharmaceuticals Inc. reported a net income of 6.06M and revenue of 12.30M, resulting in a net margin of 49.3%.

Frequently Asked Questions

Can I hold both VST and CPH.TO in my portfolio?

VST and CPH.TO have a correlation of 0.03, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.